Lupus: Jackson Laboratory researchers discover seven major molecular subgroups of SLE patients

Researchers including Jacques Banchereau of The Jackson Laboratory have uncovered distinct molecular subgroups of patients with systemic lupus erythematosus (SLE), providing an explanation for why clinical trials might fail and opening opportunities for new and more targeted treatments of the disease. Their findings are published in the journal Cell. SLE is an incurable, systemic autoimmune ["]